342 related articles for article (PubMed ID: 25440434)
21. Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
Pamuk GE; Uyanik MS; Pamuk ON; Maden M; Tapan U
Hematology; 2015 Jun; 20(5):267-71. PubMed ID: 25271869
[TBL] [Abstract][Full Text] [Related]
22. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
Moore MM; Geller AC; Warton EM; Schwalbe J; Asgari MM
J Am Acad Dermatol; 2015 Oct; 73(4):630-6. PubMed ID: 26298295
[TBL] [Abstract][Full Text] [Related]
23. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
24. Effects of chronic lymphocytic leukemia on the development and progression of malignant melanoma.
Brewer JD; Christenson LJ; Weenig RH; Weaver AL
Dermatol Surg; 2010 Mar; 36(3):368-76. PubMed ID: 20100262
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.
Sanchez-Gonzalez B; Peñalver FJ; Medina A; Guillén H; Calleja M; Gironella M; Arranz R; Sebastian E; de Oña R; Cánovas A; de la Fuente I; Grande C; Sancho JM; Perez R; Domingo E; Lopez-Lorenzo JL; Prieto E; Panizo C; Gorosquieta A; Perez I; Cervera JM; Marin M; Mencha C; Ramila E; Salar A
Leuk Res; 2012 Jun; 36(6):709-14. PubMed ID: 22154023
[TBL] [Abstract][Full Text] [Related]
26. Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study.
McBride A; Daniel S; Driessen MT; Szende A; Choudhry A; Tian M; Ariely R; Thompson S
Leuk Res; 2021 Dec; 111():106671. PubMed ID: 34530254
[TBL] [Abstract][Full Text] [Related]
27. [Aging of the population and incidence of primary acquired hemopathies in the Autonomous Community of Aragón].
Giraldo Castellano P; Franco García E; Bernal Pérez M; Huelin Domeco de Jarauta J; Rubio-Félix D; Giralt Raichs M
Rev Esp Salud Publica; 1998; 72(6):559-70. PubMed ID: 10050606
[TBL] [Abstract][Full Text] [Related]
28. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
29. Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study.
Adami HO; Tsaih S; Lambe M; Hsieh C; Adami J; Trichopoulos D; Melbye M; Glimelius B
Int J Cancer; 1997 Jan; 70(2):155-8. PubMed ID: 9009153
[TBL] [Abstract][Full Text] [Related]
30. Richter's syndrome with identical immunoglobulin gene rearrangements in the chronic lymphocytic leukemia and the supervening non-Hodgkin lymphoma.
Michiels JJ; van Dongen JJ; Hagemeijer A; Sonneveld P; Ploemacher RE; Adriaansen HJ; van der Kwast TH; Brederoo P; Abels J
Leukemia; 1989 Nov; 3(11):819-24. PubMed ID: 2811481
[TBL] [Abstract][Full Text] [Related]
31. Occupation and risk of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Zheng T; Blair A; Zhang Y; Weisenburger DD; Zahm SH
J Occup Environ Med; 2002 May; 44(5):469-74. PubMed ID: 12024692
[TBL] [Abstract][Full Text] [Related]
32. Survival patterns among lymphoma patients with a family history of lymphoma.
Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
[TBL] [Abstract][Full Text] [Related]
34. Increased adiponectin level in non-Hodgkin lymphoma and its relationship with interleukin-10. Correlation with clinical features and outcome.
Pamuk GE; Turgut B; Demir M; Vural O
J Exp Clin Cancer Res; 2006 Dec; 25(4):537-41. PubMed ID: 17310845
[TBL] [Abstract][Full Text] [Related]
35. Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma.
Asgari MM; Warton EM; Quesenberry CP; Koralek DO; Taylor M
J Am Acad Dermatol; 2014 Sep; 71(3):521-8. PubMed ID: 24856040
[TBL] [Abstract][Full Text] [Related]
36. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
37. Incidence of progressive multifocal leukoencephalopathy in patients without HIV.
Amend KL; Turnbull B; Foskett N; Napalkov P; Kurth T; Seeger J
Neurology; 2010 Oct; 75(15):1326-32. PubMed ID: 20938025
[TBL] [Abstract][Full Text] [Related]
38. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
[TBL] [Abstract][Full Text] [Related]
39. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Dennie TW; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
[TBL] [Abstract][Full Text] [Related]
40. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.
Duberg AS; Nordström M; Törner A; Reichard O; Strauss R; Janzon R; Bäck E; Ekdahl K
Hepatology; 2005 Mar; 41(3):652-9. PubMed ID: 15723449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]